News
Polycythemia vera (PV) is a blood cancer that begins in the marrow of your bones, the soft center where new blood cells grow. It causes your marrow to make too many red blood cells so your blood ...
What is a bone marrow test? A bone marrow test is a way of testing cells from your bone marrow. Bone marrow is the spongy tissue inside your bones that makes blood cells. To find out whether there are ...
(Credit: iStock/Getty Images) Bone marrow is the soft, spongy tissue in the middle of most of your bones. It contains hematopoietic stem cells or blood ... and a bone marrow biopsy to look for ...
Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that seed cancer relapses, researchers report. The aptamers -- short ...
leukemia stem cells have the ability to evade chemotherapy by retreating to the bone marrow, since they share markers and properties, Dwivedy said. The cancerous cells can lurk, sometimes for ...
3, 2025 — Drug-carrying DNA aptamers can deliver a one-two punch to leukemia ... cancer cells that are harder for prior CAR-T therapies to detect and ... Feb. 25, 2025 — A bone marrow ...
He was rushed to the hospital and diagnosed with aplastic anemia, a rare bone marrow disease. The condition causes the body to stop producing enough new blood cells, leaving patients fatigued and ...
3d
News-Medical.Net on MSNGenetic fusion drives unexpectedly fast growth in chronic myeloid leukemiaA new study has unveiled when chronic myeloid leukemia, a type of cancer that affects the blood and bone marrow, arises in ...
Caspian Oliai, MD, MS, medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center, discusses findings from the phase 3 Precision-T trial of Orca-T in acute leukemia and ...
A nationwide team led by researchers at Baylor College of Medicine, Texas Children's Hospital and UPMC Children's Hospital of ...
Immunosuppressive therapy improves pancytopenia in severe aplastic anemia.However, its effects are not long-lasting as evidenced by a modest 2-year EFS rate of just 46%, prompting the need for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results